<DOC>
	<DOCNO>NCT00384930</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , parallel-design , multinational , 12-week study compare efficacy , dose response , safety tadalafil day versus placebo men sign symptom benign prostatic hyperplasia , include low urinary tract symptom .</brief_summary>
	<brief_title>Study Tadalafil Once-a Day 12 Weeks Men With Signs Symptoms Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Males , 45 year old , benign prostatic hyperplasia , include low urinary tract symptom least 6 month prior Visit 1 International Prostate Symptom Score ( IPSS ) great equal 13 Visit 2 . Agree use approve experimental benign prostatic hyperplasia erectile dysfunction treatment anytime study Have take finasteride dutasteride therapy , low urinary tract symptom ( LUTS ) therapy phosphodiesterase type 5 ( PDE5 ) inhibitor specify duration time prior Visit 2 . Have prostate specific antigen ( PSA ) score within acceptable range define study negative biopsy prostate cancer within 12 month Visit 1 . History urinary retention lower urinary tract ( bladder ) stone 6 month start study History bladder outlet obstruction urethral obstruction due stricture , valve , sclerosis , tumor . History cardiac condition include angina require certain treatment nitrate , heart disease coronary condition include myocardial infarction , bypass surgery , angioplasty stent placement specify time start study . Certain neurological condition associate bladder problem injury brain spinal cord within specified time start study . Nitrate use</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>